FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

ISABELLE RAY COQUARD

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

France

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Living Beings

Young Adult

Physiology

Co-author Network

Publications

TOP 3
Anna Patrikidou; D Pérol; ISABELLE RAY COQUARD; M Rios; Antoine Adenis; F Bertucci; Jean-Yves Blay; Binh Nguyen Bui; Sylvie Chabaud; Christine Chevreau; Didier Cupissol; Julien Domont; Florence Duffaud; Axel Le Cesne
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Patricia Pautier; N Pinto; Sophie Piperno-Neumann; ISABELLE RAY COQUARD; A Reynaud-Bougnoux; F Selle; B Weber; F Bertucci; Emmanuelle Bompas; C Delcambre; Florence Duffaud; Pierre Duvillard; Anne Floquet; Laurence Gladieff; C Guillemet; Christine Haie-Meder; N Isambert; Pierre Kerbrat; Rémy Largillier; Catherine Lhommé; G Netter-Pinon; P Opinel; Annie Rey
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
ISABELLE RAY COQUARD; C Roemer-Becuwe; B Weber; P Bougnoux; M Fabbro; L Favier; A Floquet; F Joly; Désiré Paraiso; Anne Plantade; Eric Pujade-Lauraine
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of ISABELLE RAY COQUARD (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Patrikidou; D Pérol; ISABELLE RAY COQUARD; M Rios; Antoine Adenis; F Bertucci; Jean-Yves Blay; Binh Nguyen Bui; Sylvie Chabaud; Christine Chevreau; Didier Cupissol; Julien Domont; Florence Duffaud; Axel Le Cesne
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):1087-93.
2013: Patricia Pautier; N Pinto; Sophie Piperno-Neumann; ISABELLE RAY COQUARD; A Reynaud-Bougnoux; F Selle; B Weber; F Bertucci; Emmanuelle Bompas; C Delcambre; Florence Duffaud; Pierre Duvillard; Anne Floquet; Laurence Gladieff; C Guillemet; Christine Haie-Meder; N Isambert; Pierre Kerbrat; Rémy Largillier; Catherine Lhommé; G Netter-Pinon; P Opinel; Annie Rey
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):1099-104.
2013: ISABELLE RAY COQUARD; C Roemer-Becuwe; B Weber; P Bougnoux; M Fabbro; L Favier; A Floquet; F Joly; Désiré Paraiso; Anne Plantade; Eric Pujade-Lauraine
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.
British journal of cancer 2013;108(9):1771-7.
2013: Nicolas Carrabin; Pierre Meeus; Olivier Tredan; Isabelle Treilleux; ISABELLE RAY COQUARD
Primary ovarian borderline tumor in the inguinal lymph node.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2013;32(2):167-70.
2013: Julien Péron; Irene Philip; ISABELLE RAY COQUARD; Catherine Sebban; Olivier Tredan; Thomas Bachelot; Pierre Biron; Christophe Borg; Philippe A Cassier; Christophe Caux; Sylvie Chabaud; Gilles Clapisson; Claire Cropet; Inthidar Labidi Galy; Christine Menetrier-Caux; David Perol; Jean-Yves Blay
CD4 lymphopenia to identify end-of-life metastatic cancer patients.
European journal of cancer (Oxford, England : 1990) 2013;49(5):1080-9.
2013: J Thariat; A Thyss; J Usseglio; C Verite; K Aldabbagh; G Bar-Sela; Emmanuelle Bompas; A Brouchet; L Brugières; Loïc Chaigneau; O Dassonville; T de La MotteRouge; A Italiano; Pierre Kerbrat; J E Kurtz; J P Lotz; P Maingon; P Y Marcy; R C Miller; G Odin; Gwénaël Raoul; ISABELLE RAY COQUARD; H Reychler; E Saada; S Salas; J Sarini; T Schouman; S Sohawon; Morbize Julieron
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):824-31.
2013: Thomas Bachelot; Claire Cropet; ISABELLE RAY COQUARD; Eric Pujade-Lauraine
Reply to J.-H. Choi et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(4):511.
2013: Alice Levard; Pierre Méeus; Dominique Ranchère; ISABELLE RAY COQUARD; Jean-Yves Blay; Olfa Derbel; Philippe A Cassier
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.
BMC cancer 2013;13():109.
2013: Jean-Yves Blay; Emmanuelle Bompas; Binh Bui; Philippe A Cassier; Loïc Chaigneau; Jean-Michel Coindre; Olivier Collard; Gauthier Decanter; Olfa Derbel; Florence Duffaud; Nicolas Isambert; Antoine Italiano; Axel Le Cesne; Nadia Badri; François Bertucci; ISABELLE RAY COQUARD; Maria Rios; Patrick Zintl; Nicolas Penel
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.
BMC cancer 2013;13():64.
2012: ISABELLE RAY COQUARD; Ruediger Rueger; Lyubomir T Vassilev; Jianguo Zhi; Jean-Yves Blay; Meichun Ding; David Geho; Bradford Graves; Florian Heil; Antoine Italiano; Axel Le Cesne; Steven A Middleton; Gwen L Nichols; Nicolas Penel; Binh Nguyen Bui
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.
The lancet oncology 2012;13(11):1133-40.
2012: Irène Asmane; Jean-Pierre Bergerat; Laurent Alberti; Philippe A Cassier; Anne-Valérie Decouvelaere; Adeline Duc; Jean-Emmanuel Kurtz; Perrine Marec-Berard; Dominique Ranchère; ISABELLE RAY COQUARD; Emmanuel Watkin; Jean-Yves Blay
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
European journal of cancer (Oxford, England : 1990) 2012;48(16):3027-35.
2012: Giuseppe Mastrangelo; Cristina Montesco; Dominique Ranchère-Vince; ISABELLE RAY COQUARD; Jean-Yves Blay; Alessandra Buja; Luca Cegolon; Jean-Michel Coindre; Angelo Paolo Dei Tos; Françoise Ducimetière; Emanuela Fadda; Ugo Fedeli; Alvise Frasson; Carlo Riccardo Rossi
Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.
Cancer 2012;118(21):5339-48.
2012: Ursula Matulonis; ISABELLE RAY COQUARD; Sudarshan Sharma; Xiaofei Zhou; Hadi Danaee; Salvatore A Del Prete; Howard Fingert; Sharad Ghamande; Michael S Gordon; Elzbieta Kutarska; Hua Liu; Russell J Schilder
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
Gynecologic oncology 2012;127(1):63-9.
2012: ISABELLE RAY COQUARD; Carlo Riccardo Rossi; L Toffolatti; Antonella Vecchiato; S Albert; Jean-Yves Blay; D Cellier; Jean-Michel Coindre; P Cousin; A V Decouvelaere; A P Dei Tos; Antoine Lurkin; S Mathoulin-Pélissier; Maria Cristina Montesco; Dominique Ranchère-Vince
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(9):2442-9.
2012: ISABELLE RAY COQUARD; David Thomas
Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emerges.
Nature reviews. Clinical oncology 2012;9(8):431-2.
2012: Thomas Bachelot; Céline Bourgier; Claire Cropet; Marc Debled; Claude El Kouri; Jean-Christophe Eymard; Jean-Marc Ferrero; Gilles Freyer; Eric Legouffe; Sophie Abadie-Lacourtoisie; Djelila Allouache; ISABELLE RAY COQUARD; Dominique Spaëth; Eric Pujade-Lauraine
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(22):2718-24.
2012: ISABELLE RAY COQUARD; Axel Le Cesne
A role for maintenance therapy in managing sarcoma.
Cancer treatment reviews 2012;38(5):368-78.
2012: Jean-Emmanuel Kurtz; ISABELLE RAY COQUARD
PI3 kinase inhibitors in the clinic: an update.
Anticancer research 2012;32(7):2463-70.
2012: Florian Scotté; Vincent Launay-Vacher; ISABELLE RAY COQUARD
[Iron deficiency and anemia in oncology].
Bulletin du cancer 2012;99(5):563-70.
2012: ISABELLE RAY COQUARD; michel salzet; Xavier Sastre-Garau; Sophie Taieb; Charles Theillet; Gwendal Lazennec; Eric Leblanc; Fabrice Lecuru; Frédérique Penault Llorca; Laurent Poulain; Eric Pujade-Lauraine; Patrick Arveux; Franck bonnetain; Christophe Caux; Franck Chauvin; Véronique Christophe; Eric Deutsch; Mojgan Devouassoux; Christine Haie-Meder; Hélène Hoarau; Florence Joly
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved].
Bulletin du cancer 2012;99(4):479-98.
2012: Patrick Castel; Christelle Faure; Jean-Paul Guastalla; Nicole Guerin; Antoine Lurkin; Perrine Marec-Berard; Pierre Meeus; Herve Mignotte; Dominique Ranchere-Vince; Marie-Pierre Sunyach; Louis Tassy; Philippe Thiesse; Isabelle Treilleux; Thomas Bachelot; Jean-Yves Blay; ISABELLE RAY COQUARD
Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organization.
Bulletin du cancer 2012;99(4):E34-42.
2012: Sarah Zimmer-Rapuch; Fabien Brocard; Nicolas Janus; Vincent Launay-Vacher; Stéphanie Lheureux; ISABELLE RAY COQUARD
[Anticancer drugs management in renal insufficiency patients].
Bulletin du cancer 2012;99(3):323-31.
2012: Philippe Beuzeboc; Gilbert Deray; Joseph GLIGOROV; Nicolas Janus; Christophe Le Tourneau; ISABELLE RAY COQUARD; Jean-Philippe Spano; Vincent Launay-Vacher
[Renal insufficiency and breast cancer].
Bulletin du cancer 2012;99(3):309-15.
2012: B Bui-Nguyen; Christine Chevreau; Jean-Michel Coindre; D Cupissol; A Italiano; M Jimenez; J P Lotz; Simone Mathoulin-Pélissier; N Penel; ISABELLE RAY COQUARD; A Thyss; J O Bay; Jean-Yves Blay; Françoise Bonichon
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):777-84.
2012: A du Bois; P Harter; ISABELLE RAY COQUARD; I Vergote; Pauline Wimberger; L B Curtis; I Mitrica
Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group.
British journal of cancer 2012;106(4):629-32.
2012: ISABELLE RAY COQUARD; Florian Scotté; Laurent Cals; Jean-François Morère; Eric-Charles Antoine
Management of anemia in advanced breast and lung cancer patients in daily practice: results of a French survey.
Advances in therapy 2012;29(2):124-33.
2012: Julien Peron; ISABELLE RAY COQUARD; Olivier Tredan; Isabelle Treilleux; Thomas Bachelot; Bertrand Favier; Sana Intidhar Labidi Galy; Jean-Paul Guastalla
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.
Bulletin du cancer 2012;99(2):E18-25.
2012: Nicolas Penel; ISABELLE RAY COQUARD; Y M Robin; Jacques-Olivier Bay; F Bertucci; Jean-Yves Blay; Emmanuelle Bompas; Binh Nguyen Bui; Loïc Chaigneau; Didier Cupissol; C Delcambre; F Duffaud; C Guillemet; N Isambert; A Italiano
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):517-23.
2012: David Pérol; Xavier Pivot; Jocelyne Provençal; Cécile Agostini; Thomas Bachelot; Agathe Bajard; David Coeffic; Jean-Paul Guastalla; Anne-Claire Hardy-Bessard; JP Jacquin; Jean-Pierre Martin; ISABELLE RAY COQUARD
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
BMC cancer 2012;12():603.
2012: Pierre Heudel; Pierre Meeus; Dominique Ranchère-Vince; Jean Yves Blay; Philippe A Cassier; Olfa Derbel; Armelle Dufresne; Philippe Thiesse; ISABELLE RAY COQUARD
Pazopanib for the treatment of soft-tissue sarcoma.
Clinical pharmacology : advances and applications 2012;4():65-70.
2012: Florence Duffaud; Armelle Dufresne; Caroline Even; Thanh Khoa-Huynh; Axel Le Cesne; ISABELLE RAY COQUARD; Sebastien Salas; Emmanuelle Bompas; Sylvie Bonvalot; Philippe A Cassier; Francoise Ducimetiere; Jean-Yves Blay
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients.
Clinical sarcoma research 2012;2(1):11.
2012: Lionel Perrier; Dominique Ranchère-Vince; Carlo Riccardo Rossi; Paolo Sandonà; Carole Siani; Philippe Thiesse; Antonella Vecchiato; Christophe Bergeron; Pierre Biron; Jean-Yves Blay; Alessandra Buja; Jean-Michel Coindre; Anne-Valérie Decouvelaere; Angelo Paolo Dei Tos; Françoise Ducimetière; François Noël Gilly; Giuseppe Mastrangelo; ISABELLE RAY COQUARD
Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions.
BMC health services research 2012;12():82.
2012: ISABELLE RAY COQUARD; Yves-Marie Robin; Jacques-Olivier Bay; Jean-Yves Blay; Emmanuelle Bompas; Guilhem Bousquet; Christine Chevreau; Stéphanie Clisant; Olivier Collard; Didier Cupissol; Charles Fournier; Eric Gauthier; Nicolas Isambert; Antoine Italiano; Axel Le Cesne; Laurent Lemaitre; Nicolas Penel; Sophie Piperno-Neumann
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
The oncologist 2012;17(2):260-6.
2011: Olivier Tredan; Antoine Arnaud; Séverine Racadot; ISABELLE RAY COQUARD; Jean-Paul Guastalla
[Cervix cancer and corpus cancer of the uterus].
La Revue du praticien 2011;61(10):1435-42.
2011: Pierre-Étienne Heudel; ISABELLE RAY COQUARD; Olivier Tredan; Isabelle Treilleux; Jean-Paul Guastalla; Thomas Bachelot
[Antihormonal therapy in breast cancer and mTOR inhibitors].
Bulletin du cancer 2011;98(12):1431-7.
2011: Philippe A Cassier; Maria Chelghoum; Aurélie Dutour; Pierre Heudel; Sana Intidhar Labidi-Galy; Pierre Méeus; ISABELLE RAY COQUARD; laurent alberti; Jean-Yves Blay
Therapeutic pipeline for soft-tissue sarcoma.
Expert opinion on pharmacotherapy 2011;12(16):2479-91.
2011: ISABELLE RAY COQUARD
Maintenance therapy in the treatment of sarcoma.
Clinical advances in hematology & oncology : H&O 2011;9(10):773-4.
2011: Irène Asmane; Agathe Bajard; Jean-Pierre Bergerat; David Coeffic; Armelle Dufresne; Jean-Paul Guastalla; Jean-Emmanuel Kurtz; Intidhar Labidi Galy; Pierre Meeus; Isabelle Moullet; Olivier Tredan; Lionel Vincent; Philippe Ardisson; ISABELLE RAY COQUARD
Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
Bulletin du cancer 2011;98(9):80-9.
2011: Jean-Yves Blay; Philippe A Cassier; ISABELLE RAY COQUARD
Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S385-8.
2011: Sana Intidhar Labidi-Galy; Pierre Meeus; Christine Ménétrier-Caux; François Mithieux; ISABELLE RAY COQUARD; Vanja Sisirak; Olivier Tredan; Isabelle Treilleux; Jean-Yves Blay; Alexandre Cassignol; Christophe Caux; Jean-Damien Combes; Isabelle Durand; Julien Faget; Michael Gobert; Agathe Bajard; Nathalie Bendriss-Vermare
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.
Cancer research 2011;71(16):5423-34.
2011: Florence Joly; Karin Boman; Tiziana Dell'Anna; Mark Donoghoe; Michel Fabbro; Gabriella Ferrandina; Jens Huober; ISABELLE RAY COQUARD; Alexander Reinthaller; Akira Sugimoto; Michelle Vaughan; Ignace Vergote; Eric Pujade-Lauraine
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.
Gynecologic oncology 2011;122(2):226-32.
2011: Antoine Italiano; Jose Jimeno; Ian Judson; Audrey Laroche; Armelle Laurand; Axel Le Cesne; Antonio Nieto; Jean-Yves Blay; Binh Bui; Paolo Casali; Jean-Michel Coindre; ISABELLE RAY COQUARD; Jacques Robert; Roberta Sanfilippo; Juan-Carlos Tercero; Philippe Pourquier
ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.
Cancer 2011;117(15):3445-56.
2011: Guillaume Galy; Jean-Paul Guastalla; Sana Intidhar Labidi-Galy; Jean-François Latour; David Perol; ISABELLE RAY COQUARD; Olivier Tredan; Thomas Bachelot; Pierre Biron; Jean-Yves Blay; Bertrand Favier
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006.
Breast cancer research and treatment 2011;128(1):187-95.
2011: ISABELLE RAY COQUARD
An increasing role for trabectedin in gynecological cancers: efficacy in uterine sarcomas.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21 Suppl 1():S3-5.
2011: N Penel; A Le Cesne; B N Bui; D Perol; E G Brain; ISABELLE RAY COQUARD; C Guillemet; C Chevreau; D Cupissol; S Chabaud; M Jimenez; F Duffaud; S Piperno-Neumann; L Mignot; J-Y Blay
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(2):452-7.
2011: Françoise Ducimetière; Luc Istier; Antoine Lurkin; Christine Muller; Michel Péoc'H; Dominique Ranchère-Vince; Laurent Alberti; Christophe Bergeron; Jean-Yves Blay; Pierre-Paul Bringuier; Dominic Cellier; Philippe Chalabreysse; Anne-Valérie Decouvelaere; Anne-Marie Schott; Jean-Yves Scoazec; ISABELLE RAY COQUARD
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.
PloS one 2011;6(8):e20294.
2011: Thomas Bachelot; Agathe Bajard; Martial Boisseau; David Coeffic; Dominique Dramais; Rose-Marie Ferri-Dessens; Jean-Paul Guastalla; Régis Kaphan; Corina Oprea; Jocelyne Provencal; ISABELLE RAY COQUARD; Cécile Agostini; David Perol
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer.
Oncology 2011;80(3-4):262-8.
2011: Philippe A Cassier; Christophe Caux; Sophie Goddard-Léon; Serge Lebecque; Christine Ménétrier-Caux; Hervé Mignotte; Jean-Jacques Pin; ISABELLE RAY COQUARD; Olivier Trédan; Isabelle Treilleux; Thomas Bachelot; Clarisse Bathélémy-Dubois; Nathalie Bendriss-Vermare; Jean-Yves Blay
Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
BMC cancer 2011;11():213.
2011: Olivier Trédan; ISABELLE RAY COQUARD; Gisèle Chvetzoff; Paul Rebattu; Agathe Bajard; Sylvie Chabaud; David Pérol; Chadi Saba; Florent Quiblier; Jean-Yves Blay; Thomas Bachelot
Validation of prognostic scores for survival in cancer patients beyond first-line therapy.
BMC cancer 2011;11():95.
2011: Aurore Blesius; Philippe A Cassier; François Bertucci; Jerome Fayette; ISABELLE RAY COQUARD; Binh Bui; Antoine Adenis; Maria Rios; Didier Cupissol; David Pérol; Jean-Yves Blay; Axel Le Cesne
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.
BMC cancer 2011;11():72.
2011: A Berthe; A Duclos; ISABELLE RAY COQUARD; Cyrille Colin; N Bleyzac
[Assessment of adherence to Afssaps guidelines for the prescription of antifungals in pediatric hemato-oncology].
Médecine et maladies infectieuses 2011;41(1):25-32.
2010: Jérôme Alexandre; ISABELLE RAY COQUARD; F Selle; A Floquet; P Cottu; B Weber; C Falandry; D Lebrun; Eric Pujade-Lauraine
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(12):2377-81.
2010: Vincent Launay-Vacher; Joseph GLIGOROV; Christophe Le Tourneau; Nicolas Janus; Jean-Philippe Spano; ISABELLE RAY COQUARD; Stéphane Oudard; Xavier Pourrat; Jean-François Morere; Gilbert Deray; Philippe Beuzeboc
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Breast cancer research and treatment 2010;124(3):745-53.
2010: ISABELLE RAY COQUARD; P Laplaige; N Vey; B Asselain; M Urbieta
A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia.
Current medical research and opinion 2010;26(11):2653-60.
2010: Axel Le Cesne; ISABELLE RAY COQUARD; Binh Nguyen Bui; Antoine Adenis; Maria Rios; François Bertucci; Florence Duffaud; Christine Chevreau; Didier Cupissol; Angela Cioffi; Jean-François Emile; Sylvie Chabaud; David Pérol; Jean-Yves Blay
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.
The lancet oncology 2010;11(10):942-9.
2010: ISABELLE RAY COQUARD; Béatrice Weber; Jean Pierre Lotz; Christophe Tournigand; Jocelyne Provencal; Didier Mayeur; Isabelle Treilleux; Désiré Paraiso; Pierre Duvillard; Eric Pujade-Lauraine
Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
Gynecologic oncology 2010;119(1):53-9.
2010: Patrick Schöffski; P Reichardt; J-Y Blay; Herlinde Dumez; J A Morgan; ISABELLE RAY COQUARD; N Hollaender; A Jappe; G D Demetri
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(10):1990-8.
2010: A Dufresne; F Bertucci; N Penel; Axel Le Cesne; Binh Nguyen Bui; M Tubiana-Hulin; ISABELLE RAY COQUARD; Didier Cupissol; Christine Chevreau; David Perol; A Goncalves; M Jimenez; P P Bringuier; Jean-Yves Blay
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
British journal of cancer 2010;103(4):482-5.
2010: Patrick Schöffski; Jean-Yves Blay; Jacques De Greve; Etienne Brain; Jean-Pascal Machiels; Jean-Charles Soria; Stefan Sleijfer; Pascal Wolter; ISABELLE RAY COQUARD; Christel Fontaine; Gerd Munzert; Holger Fritsch; Gertraud Hanft; Claire Aerts; Jérome Rapion; Anouk Allgeier; Jan Bogaerts; Denis Lacombe
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI).
European journal of cancer (Oxford, England : 1990) 2010;46(12):2206-15.
2010: P A Cassier; F Ducimetière; A Lurkin; D Ranchère-Vince; J-Y Scoazec; P-P Bringuier; A-V Decouvelaere; P Méeus; D Cellier; J-Y Blay; ISABELLE RAY COQUARD
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region.
British journal of cancer 2010;103(2):165-70.
2010: F Ducimetière; A Lurkin; D Ranchère-Vince; A-V Decouvelaere; S Isaac; C Claret-Tournier; Y Suignard; D Salameire; D Cellier; laurent alberti; P-P Bringuier; J-Y Blay; ISABELLE RAY COQUARD
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region].
Bulletin du cancer 2010;97(6):629-41.
2010: Philippe A Cassier; D Pissaloux; laurent alberti; ISABELLE RAY COQUARD; Jean-Yves Blay
[Targeted treatment of rare connective tissue tumors and sarcomas].
Bulletin du cancer 2010;97(6):693-700.
2010: Axel Le Cesne; Jean-Yves Blay; Binh Nguyen Bui; Olivier Bouché; Antoine Adenis; Julien Domont; Angela Cioffi; ISABELLE RAY COQUARD; Nathalie Lassau; Sylvie Bonvalot; Alain Moussy; Jean-Pierre Kinet; Olivier Hermine
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
European journal of cancer (Oxford, England : 1990) 2010;46(8):1344-51.
2010: N Carrabin; F Mithieux; P Meeus; O Trédan; J-P Guastalla; T Bachelot; S I Labidi; I Treilleux; M Rivoire; ISABELLE RAY COQUARD
Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.
Bulletin du cancer 2010;97(4):E23-32.
2010: Andreas du Bois; Alexander Reuss; Philipp Harter; Eric Pujade-Lauraine; ISABELLE RAY COQUARD; Jacobus Pfisterer
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1733-9.
2010: Sergio Pecorelli; ISABELLE RAY COQUARD; O Tredan; Nicoletta Colombo; G Parma; G Tisi; D Katsaròs; C Lhommé; Andrea Lissoni; J B Vermorken; Andreas du Bois; A Poveda; L Frigerio; P Barbieri; P Carminati; S Brienza; J P Guastalla
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(4):759-65.
2010: Nicolas Penel; Jean-Pierre Delord; Marie-Edith Bonneterre; Thomas Bachelot; ISABELLE RAY COQUARD; Jean-Yves Blay; Laurent Benjamin Pascal; Cécile Borel; Thomas Filleron; Antoine Adenis; Jacques Bonneterre
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.
Investigational new drugs 2010;28(1):76-82.
2010: Philippe A Cassier; Aude Duret; Olivier Trédan; Nicolas Carrabin; Pierre Méeus; Isabelle Treilleux; Jean-Paul Guastalla; ISABELLE RAY COQUARD
New developments in treatment of ovarian carcinoma: focus on trabectedin.
Cancer management and research 2010;2():233-42.
2010: Rhizlane Belbaraka; Olivier Trédan; ISABELLE RAY COQUARD; Giselle Chvetzoff; Agathe Bajard; David Pérol; Nabil Ismaili; Mohammed Ismaili; Hassan Errihani; Thomas Bachelot; Paul Rebattu
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer.
BMC research notes 2010;3():164.
2010: Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy De Laroche; Jean Yves Blay; ISABELLE RAY COQUARD
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.
BMC cancer 2010;10():150.
2010: Giuseppe Mastrangelo; Emanuela Fadda; Luca Cegolon; Maria Cristina Montesco; ISABELLE RAY COQUARD; Alessandra Buja; Ugo Fedeli; Alvise Frasson; Paolo Spolaore; Carlo R Rossi
A European project on incidence, treatment, and outcome of sarcoma.
BMC public health 2010;10():188.
2010: ISABELLE RAY COQUARD; P Pautier; E Pujade-Lauraine; P Méeus; P Morice; I Treilleux; P Duvillard; J Alexandre; C Lhommé; F Selle; Jp Guastalla
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
Bulletin du cancer 2010;97(1):123-35.
2010: Jérôme Fayette; Helen Boyle; Sylvie Chabaud; Bertrand Favier; Catherine Engel; Philippe Cassier; Philippe Thiesse; Pierre Méeus; Marie-Pierre Sunyach; Gualter Vaz; ISABELLE RAY COQUARD; Dominique Ranchère; Anne-Valérie Decouvelaere; laurent alberti; David Pérol; Jean-Yves Blay
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution.
Anti-cancer drugs 2010;21(1):113-9.
2009: Vincent Launay-Vacher; Jorge Ayllon; Nicolas Janus; Jean-Philippe Spano; ISABELLE RAY COQUARD; Joseph GLIGOROV; Xavier Pourrat; Jean-François Morere; Philippe Beuzeboc; Gilbert Deray; Stéphane Oudard
Drug management of prostate cancer: prevalence and consequences of renal insufficiency.
Clinical genitourinary cancer 2009;7(3):E83-9.
2009: George D Demetri; Paolo G Casali; Jean-Yves Blay; Margaret von Mehren; Jeffrey A Morgan; Rossella Bertulli; ISABELLE RAY COQUARD; Philippe Cassier; Monica Davey; Hossein Borghaei; Daniel Pink; Maria Debiec-Rychter; Wing Cheung; Stuart M Bailey; Maria Luisa Veronese; Annette Reichardt; Elena Fumagalli; Peter Reichardt
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5910-6.
2009: ISABELLE RAY COQUARD; Claire Cropet; Martine Van Glabbeke; Catherine Sebban; Axel Le Cesne; Ian Judson; Olivier Tredan; Jaap Verweij; Pierre Biron; Inthidar Labidi; Jean-Paul Guastalla; Thomas Bachelot; David Perol; Sylvie Chabaud; Pancras Hogendoorn; Philippe A Cassier; Armelle Dufresne; Jean-Yves Blay
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
Cancer research 2009;69(13):5383-91.
2009: Jean-Yves Blay; Antoine Adenis; ISABELLE RAY COQUARD; Philippe A Cassier; Axel Le Cesne
Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?
Current opinion in oncology 2009;21(4):360-6.
2009: Stefan Sleijfer; ISABELLE RAY COQUARD; Zsuzsa Papai; Axel Le Cesne; Michelle Scurr; Patrick Schöffski; Françoise Collin; Lini Pandite; Sandrine Marreaud; Annick De Brauwer; Martine Van Glabbeke; Jaap Verweij; Jean-Yves Blay
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3126-32.
2009: Suzanne George; J Y Blay; P G Casali; A Le Cesne; P Stephenson; Samuel E DePrimo; C S Harmon; C N J Law; Jeffrey A Morgan; ISABELLE RAY COQUARD; V Tassell; D P Cohen; George D Demetri
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.
European journal of cancer (Oxford, England : 1990) 2009;45(11):1959-68.
2009: Perrine Marec-Berard; Pascal Chastagner; Diana Kassab-Chahmi; Nicole Casadevall; Christian Marchal; Jean-Louis Misset; ISABELLE RAY COQUARD
2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer.
Pediatric blood & cancer 2009;53(1):7-12.
2009: Axel Le Cesne; Julien Domont; Angela Cioffi; S Bonvalot; P Terrier; ISABELLE RAY COQUARD; V Alfaro; C Lebedinsky; P Santabarbara; Jean-Yves Blay
Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma.
Drugs of today (Barcelona, Spain : 1998) 2009;45(6):403-21.
2009: ISABELLE RAY COQUARD; S Dussart; C Goillot; D Mayeur; P Debourdeau; H Ghesquieres; T Bachelot; A Le Cesne; B Anglaret; C Agostini; J-P Guastalla; L Lancry; P Biron; F Desseigne; J-Y Blay
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):1105-12.
2009: Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Mike Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Dirk Rades; David P Steensma; Benjamin Djulbegovic; Martin F Fey; ISABELLE RAY COQUARD; Mitchell Machtay; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
Lancet 2009;373(9674):1532-42.
2009: Sana Intidhar Labidi; Thomas Bachelot; ISABELLE RAY COQUARD; Karim Mosbah; Isabelle Treilleux; Jerome Fayette; Bertrand Favier; Guillaume Galy; Jean-Yves Blay; Jean-Paul Guastalla
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.
Clinical breast cancer 2009;9(2):118-21.
2009: Vincent Launay-Vacher; Jean-Philippe Spano; Nicolas Janus; Joseph GLIGOROV; ISABELLE RAY COQUARD; Stéphane Oudard; Xavier Pourrat; Jean-François Morere; Philippe Beuzeboc; Gilbert Deray
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study.
Critical reviews in oncology/hematology 2009;70(2):124-33.
2009: P Sève; J Mackey; M Sawyer; T Lesimple; C de La Fouchardière; C Broussolle; C Dumontet; ISABELLE RAY COQUARD
Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.
Bulletin du cancer 2009;96(4):E7-17.
2009: Andreas du Bois; Alexander Reuss; Eric Pujade-Lauraine; Philipp Harter; ISABELLE RAY COQUARD; Jacobus Pfisterer
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).
Cancer 2009;115(6):1234-44.
2009: Michael Gobert; Isabelle Treilleux; Nathalie Bendriss-Vermare; Thomas Bachelot; Sophie Goddard-Leon; Vanessa Arfi; Cathy Biota; Anne Claire Doffin; Isabelle Durand; Daniel Olive; Solène Perez; Nicolas Pasqual; Christelle Faure; ISABELLE RAY COQUARD; Alain Puisieux; Christophe Caux; Jean-Yves Blay; Christine Ménétrier-Caux
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
Cancer research 2009;69(5):2000-9.
2009: ISABELLE RAY COQUARD; B Weber; J Cretin; Z Haddad-Guichard; E Lévy; A C Hardy-Bessard; M C Gouttebel; J-F Geay; A Aleba; H Orfeuvre; C Agostini; J Provencal; J M Ferrero; D Fric; N Dohollou; D Paraiso; J Salvat; E Pujade-Lauraine
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.
British journal of cancer 2009;100(4):601-7.
2009: Nicolas Penel; Sylvie Negrier; ISABELLE RAY COQUARD; Charles Ferte; Patrick Devos; Antoine Hollebecque; Michael B Sawyer; Antoine Adenis; Pascal Seve
Development and validation of a bedside score to predict early death in cancer of unknown primary patients.
PloS one 2009;4(8):e6483.
2009: Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Mike Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Maryann Napoli; Dirk Rades; David Steensma; Benjamin Djulbegovic; Martin F Fey; ISABELLE RAY COQUARD; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.
Cochrane database of systematic reviews (Online) 2009;(3):CD007303.
2009: Vincent Launay-Vacher; Reza Etessami; Nicolas Janus; Jean-Philippe Spano; ISABELLE RAY COQUARD; Stéphane Oudard; Joseph GLIGOROV; Xavier Pourrat; Philippe Beuzeboc; Gilbert Deray; Jean-François Morere
Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Lung 2009;187(1):69-74.
2008: Philippe A Cassier; Armelle Dufresne; Samia Arifi; Hiba El Sayadi; ISABELLE RAY COQUARD; Pierre-Paul Bringuier; Jean-Yves Scoazec; laurent alberti; Jean-Yves Blay
Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib.
Current gastroenterology reports 2008;10(6):555-61.
2008: Nicolas Penel; Binh Nguyen Bui; Jacques-Olivier Bay; Didier Cupissol; ISABELLE RAY COQUARD; Sophie Piperno-Neumann; Pierre Kerbrat; Charles Fournier; Sophie Taieb; Marta Jimenez; Nicolas Isambert; Frédéric Peyrade; Christine Chevreau; Emmanuelle Bompas; Etienne G C Brain; Jean-Yves Blay
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5269-74.
2008: Philippe A Cassier; ISABELLE RAY COQUARD; Marie-Pierre Sunyach; Laurence Lancry; Jean-Paul Guastalla; Céline Ferlay; Frédéric Gomez; Hervé Curé; Alain Lortholary; Line Claude; Jean-Yves Blay; Thomas Bachelot
A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer.
Cancer 2008;113(9):2532-8.
2008: Jean-Yves Blay; Margaret von Mehren; Brian L Samuels; Michael P Fanucchi; ISABELLE RAY COQUARD; Brigid Buckley; Leen Gilles; Claudia Lebedinsky; Yusri A Elsayed; Axel Le Cesne
Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6656-62.
2008: Philippe A Cassier; Armelle Dufresne; Hiba El Sayadi; Daniel Pissaloux; laurent alberti; Anne Valérie Decouvelaere; Dominique Ranchere; ISABELLE RAY COQUARD; Jean-Yves Blay
[Targeted therapy of sarcomas].
Bulletin du cancer 2008;95(10):963-74.
2008: P Sève; J Mackey; M Sawyer; T Lesimple; C de la Fouchardière; C Broussolle; C Dumontet; ISABELLE RAY COQUARD
Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2008;20(8):658-9.
2008: Philippe A Cassier; Armelle Dufresne; Samia Arifi; Hiba El Sayadi; Inthidar Labidi; ISABELLE RAY COQUARD; Séverine Tabone; Pierre Méeus; Dominique Ranchère; Marie-Pierre Sunyach; Anne-Valérie Decouvelaere; laurent alberti; Jean-Yves Blay
Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
Expert opinion on pharmacotherapy 2008;9(7):1211-22.
2008: Thomas Bachelot; Jean-Paul Guastalla; ISABELLE RAY COQUARD
[Adjuvant therapies: the example of breast cancer].
La Revue du praticien 2008;58(8):817-9.
2008: ISABELLE RAY COQUARD; Diana Kassab-Chahmi; Nicole Casadevall; Pascal Chastagner; Christian Marchal; Perrine Marec-Bérard; Jean-Louis Misset
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)].
Bulletin du cancer 2008;95(4):433-41.
2008: ISABELLE RAY COQUARD; Axel Le Cesne; Jeremy S Whelan; Patrick Schoffski; Binh N Bui; Jaap Verweij; Sandrine Marreaud; Martine Van Glabbeke; Pancras Hogendoorn; Jean-Yves Blay
A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens.
The oncologist 2008;13(4):467-73.
2008: J-Y Blay; H El Sayadi; P Thiesse; J Garret; ISABELLE RAY COQUARD
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):821-2.
2008: Yazid Belkacémi; Guilhem Bousquet; Hugo Marsiglia; ISABELLE RAY COQUARD; Nicolas Magné; Yann Malard; Magalie Lacroix; Cristina Gutierrez; Elzbieta Senkus; David Christie; Karen Drumea; Edouard Lagneau; Sidney P Kadish; Luciano Scandolaro; David Azria; Mahmut Ozsahin
Phyllodes tumor of the breast.
International journal of radiation oncology, biology, physics 2008;70(2):492-500.
2008: Samia Arifi; Hiba El Sayadi; Armelle Dufresne; ISABELLE RAY COQUARD; Jérôme Fayette; Pierre Méeus; Dominique Ranchère; Anne-Valérie Decouvelaere; laurent alberti; Séverine Tabone-Eglinger; Jean-Yves Blay; Philippe A Cassier
[Imatinib and solid tumours].
Bulletin du cancer 2008;95(1):99-106.
2007: Catherine Lhommé; F Planchamp; F Joly; E Leblanc; N Albin; C Alliot; G Auclerc; M Cappiello; Loïc Chaigneau; R Delva; Nicole Dohollou; C Guillemet; Jean-Louis Misset; ISABELLE RAY COQUARD; H Rhliouch; Emmanuel Touboul; Christophe Tournigand
[Surveillance Bulletin 2007. Guidelines for clinical practice: management of patients with malignant epithelial tumors of the ovary. First line medical treatment].
Bulletin du cancer 2007;94(12):1093-106.
2007: ISABELLE RAY COQUARD; Désiré Paraiso; Jean-Paul Guastalla; Bernard Leduc; F Guichard; C Martin; L Chauvenet; Z Haddad-Guichard; D Lepillé; Hubert Orfeuvre; H Gautier; D Castera; Eric Pujade-Lauraine
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group.
British journal of cancer 2007;97(9):1200-5.
2007: Thomas Bachelot; ISABELLE RAY COQUARD; Philippe A Cassier; Jean-Yves Blay
[Angiogenesis and breast cancer].
Bulletin du cancer 2007;94 Spec No():S203-10.
2007: ISABELLE RAY COQUARD; Thomas Bachelot; Chadi Saba; Cyrille Confavreux; Jean-François Brantus; Fadi Rustam; Hervé Ghesquière; Catherine Sebban; Pierre Biron; Jean-Paul Guastalla; Jean-Yves Blay
[Are antiangiogenic antibodies universal for solid tumor?].
Bulletin du cancer 2007;94 Spec No():S191-6.
2007: Jean-Yves Blay; Axel Le Cesne; ISABELLE RAY COQUARD; Binh Nguyen Bui; Florence Duffaud; Catherine Delbaldo; Antoine Adenis; Patrice Viens; Maria Rios; Emmanuelle Bompas; Didier Cupissol; Cecile Guillemet; Pierre Kerbrat; Jérôme Fayette; Sylvie Chabaud; Patrice Berthaud; David Perol
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1107-13.
2007: Philippe A Cassier; Armelle Dufresne; Jérôme Fayette; laurent alberti; Dominique Ranchere; ISABELLE RAY COQUARD; Jean-Yves Blay
Emerging drugs for the treatment of soft tissue sarcomas.
Expert opinion on emerging drugs 2007;12(1):139-53.
2007: Michael Leahy; ISABELLE RAY COQUARD; Jaap Verweij; Axel Le Cesne; Florence Duffaud; Pancras Hogendoorn; Camilla Fowst; Christine de Balincourt; Eugenio Donato Di Paola; Martine Van Glabbeke; Ian Judson; Jean-Yves Blay
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
European journal of cancer (Oxford, England : 1990) 2007;43(2):308-15.
2006: Pascal Seve; ISABELLE RAY COQUARD; Véronique Trillet-Lenoir; Michael Sawyer; John Hanson; Christiane Broussolle; Sylvie Negrier; Charles Dumontet; John R Mackey
Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Cancer 2006;107(11):2698-705.
2006: Jean-Yves Blay; Sylvie Bonvalot; Jérôme Fayette; Eberhart Stockle; ISABELLE RAY COQUARD; Jean-Michel Coindre; Florence Duffaud; Sophie Taieb; Marie-Pierre Sunyach; Dominique Ranchere; Pierre Meeus; Axel Le Cesne; Binh Nguyen Bui
[Neoadjuvant chemotherapy in sarcoma].
Bulletin du cancer 2006;93(11):1093-8.
2006: Cyrille Confavreux; Antoine Lurkin; N Mitton; R Blondet; Chadi Saba; Dominique Ranchère; Marie-Pierre Sunyach; Philippe Thiesse; Pierre Biron; Jean-Yves Blay; ISABELLE RAY COQUARD
Sarcomas and malignant phyllodes tumours of the breast--a retrospective study.
European journal of cancer (Oxford, England : 1990) 2006;42(16):2715-21.
2006: Jacques-Olivier Bay; ISABELLE RAY COQUARD; Jérôme Fayette; Serge Leyvraz; Stephane Cherix; Sophie Piperno-Neumann; Christine Chevreau; Nicolas Isambert; Etienne Brain; Georges Emile; Axel Le Cesne; Angela Cioffi; Fabrice Kwiatkowski; Jean-Michel Coindre; Nguyon Binh Bui; Frédéric Peyrade; Nicolas Penel; Jean-Yves Blay
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.
International journal of cancer. Journal international du cancer 2006;119(3):706-11.
2006: ISABELLE RAY COQUARD; Chadi Saba; Thomas Bachelot; Pierre Méeus; Hervé Mignotte; Rémy Blondet; Isabelle Treilleux; Marie Peix; Jean-Paul Guastalla
[Neoadjuvant chemotherapy and ovarian cancer].
Bulletin du cancer 2006;93(7):669-76.
2006: Axel Le Cesne; Bruno Landi; Sylvie Bonvalot; Geneviève Monges; ISABELLE RAY COQUARD; Florence Duffaud; B Bui Nguyen; Roland Bugat; Jean-Alain Chayvialle; P Rougier; Olivier Bouché; Françoise Bonichon; Nathalie Lassau; Daniel Vanel; Bernard Nordlinger; Eberhard Stoeckle; Pierre Meeus; Jean-Michel Coindre; Jean-Yves Scoazec; J F Emile; Dominique Ranchère; Jean-Yves Blay
[Recommendations for the management of gastro-intestinal stromal tumors].
Annales de pathologie 2006;26(3):231-4.
2006: Cécile Le Péchoux; P Pautier; Martine Delannes; Binh Nguyen Bui; Françoise Bonichon; Sylvie Bonvalot; A Chevalier-Place; Jean-Michel Coindre; Axel Le Cesne; Philippe Morice; ISABELLE RAY COQUARD; E Stöeckle; S Taieb
[Clinical practice guidelines: 2006 update of recommendations for the radiotherapeutic management of patients with soft tissue sarcoma (sarcoma of the extremity, uterine sarcoma and retroperitoneal sarcoma].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2006;10(4):185-207.
2006: ISABELLE RAY COQUARD; Christophe Borg; Thomas Bachelot; Jérôme Fayette; Laura Zufferey; Jean-Paul Guastalla; Hervé Ghesquière; Jean-Yves Blay; Catherine Sebban; Perrine Marec-Bérard; Pierre Biron
[Prognostic factors for febrile neutropenia].
Bulletin du cancer 2006;93(5):501-6.
2006: ISABELLE RAY COQUARD; Franck Chauvin; Antoine Lurkin; Françoise Ducimetière; Jean Philippe Jacquin; Cécile Agostini; Isabelle Pouchard; Bernard Meyer; Fadila Farsi; Patrick Castel; Lionel Perrier; Thierry Philip
Medical practices and cancer care networks: examples in oncology.
Bulletin du cancer 2006;93(2):E13-20.
2006: Jérôme Fayette; Jean-Yves Blay; ISABELLE RAY COQUARD
[Soft tissues sarcomas: good medical practices for an optimal management].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2006;10(1-2):3-6.
2006: Jérôme Fayette; Pierre Méeus; Marie-Pierre Sunyach; Philippe Thiesse; ISABELLE RAY COQUARD; Jean-Yves Blay
[News of the year 2005 in sarcomas].
Bulletin du cancer 2006;93(1):83-9.
2005: Jean-Yves Blay; Bruno Landi; Sylvie Bonvalot; Geneviève Monges; ISABELLE RAY COQUARD; Florence Duffaud; Nguyen Binh Bui; Roland Bugat; Jean-Alain Chayvialle; Philippe Rougier; Olivier Bouché; Françoise Bonichon; Nathalie Lassau; Daniel Vanel; Bernard Nordlinger; Eberhard Stoeckle; Pierre Meeus; Jean-Michel Coindre; Jean-Yves Scoazec; Jean-François Emile; Dominique Ranchère; Axel Le Cesne
[Recommendations for the management of GIST patients].
Bulletin du cancer 2005;92(10):907-18.
2005: Line Claude; David Perol; ISABELLE RAY COQUARD; Thierry Petit; Jean-Yves Blay; Christian Carrie; Thomas Bachelot
Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(3):334-9.
2005: Martine Van Glabbeke; Jaap Verweij; Paolo G Casali; Axel Le Cesne; Peter Hohenberger; ISABELLE RAY COQUARD; Marcus Schlemmer; Allan T van Oosterom; David Goldstein; Raf Sciot; Pancras Hogendoorn; Michelle Brown; Rossella Bertulli; Ian R Judson
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5795-804.
2005: ISABELLE RAY COQUARD; Thierry Philip; Guy De Laroche; Xavier Froger; Jean-Philippe Suchaud; Alain Voloch; Hélène Mathieu-Daudé; Antoine Lurkin; Fadila Farsi; Pierre Bertrand; Franck Chauvin
Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4414-23.
2005: Jean-Yves Blay; Sylvie Bonvalot; Paolo Casali; H Choi; M Debiec-Richter; A P Dei Tos; J-F Emile; Alessandro Gronchi; Pancras Hogendoorn; Heikki Joensuu; Axel Le Cesne; J McClure; J Mac Clure; J Maurel; N Nupponen; ISABELLE RAY COQUARD; P Reichardt; R Sciot; S Stroobants; Martine Van Glabbeke; Allan van Oosterom; George D Demetri
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):566-78.
2005: Axel Le Cesne; Jean-Yves Blay; Ian Judson; Allan van Oosterom; Jaap Verweij; John Radford; Paul Lorigan; S Rodenhuis; ISABELLE RAY COQUARD; Sylvie Bonvalot; Françoise Collin; José Jimeno; Eugenio Donato Di Paola; Martine Van Glabbeke; Ole Steen Nielsen
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):576-84.
2004: Christophe Borg; ISABELLE RAY COQUARD; Irène Philip; Gilles Clapisson; Nathalie Bendriss-Vermare; Christine Menetrier-Caux; Catherine Sebban; Pierre Biron; Jean-Yves Blay
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
Cancer 2004;101(11):2675-80.
2004: Jean-Yves Blay; ISABELLE RAY COQUARD
[Cancer: epidemiology, carcinogenesis, tumor evolution, classification].
La Revue du praticien 2004;54(17):1935-42.
2004: Isabelle Treilleux; Jean-Yves Blay; Nathalie Bendriss-Vermare; ISABELLE RAY COQUARD; Thomas Bachelot; Jean-Paul Guastalla; Alain Bremond; Sophie Goddard; Jean-Jacques Pin; Clarisse Barthelemy-Dubois; Serge Lebecque
Dendritic cell infiltration and prognosis of early stage breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7466-74.
2004: Patrick Castel; Jean-Yves Blay; Pierre Meeus; Marie-Pierre Sunyach; Dominique Ranchère-Vince; Philippe Thiesse; Christophe Bergeron; Perrine Marec-Bérard; Antoine Lurkin; ISABELLE RAY COQUARD
[Organization and impact of the multidisciplinary committee in oncology].
Bulletin du cancer 2004;91(10):799-804.
2004: Vincent Baty; Jean-Yves Blay; Véronique Michalet; Bénédicte Prost; Catherine Agard; Dominique Ranchère-Vince; Eric Fontaumard; ISABELLE RAY COQUARD
[Asymptomatic stromal tumor of the colon revealed by classic Kaposi's sarcoma in an HIV negative patient].
Gastroentérologie clinique et biologique 2004;28(10 Pt 1):925-7.
2004: Catherine Lhommé; ISABELLE RAY COQUARD; Jean-Paul Guastalla; Anne Bataillard; Laurence Thomas; Pascal Bonnier; Daniel Dargent; Nicole Dohollou; Gérard Ganem; Jean-Pierre Lefranc; Jean-Louis Misset; Olivier Rixe; Xavier Tchiknavorian; Christophe Tournigand; Richard Villet; Thomas Bachelot; Pierre Kerbrat; Béatrice Fervers; Jean-Pierre Basuyau; Christine Cohen-Solal-le Nir; Philippe Morice; Pierre Duvillard; Eric Voog
[Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].
Bulletin du cancer 2004;91(7-8):609-20.
2004: Jean-Paul Guastalla; Thomas Bachelot; ISABELLE RAY COQUARD
[Cyclooxygenase 2 and breast cancer. From biological concepts to clinical trials].
Bulletin du cancer 2004;91 Suppl 2():S99-108.
2004: Jean-Paul Guastalla; Thomas Bachelot; ISABELLE RAY COQUARD
[Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials].
Bulletin du cancer 2004;91 Spec No():S99-108.
2004: ISABELLE RAY COQUARD
[Docetaxel and ovarian cancer].
Bulletin du cancer 2004;91(2):159-65.
2004: ISABELLE RAY COQUARD; Philippe Thiesse; Dominique Ranchère-Vince; Franck Chauvin; Jean-Yves Bobin; Marie-Pierre Sunyach; J-P Carret; B Mongodin; Perrine Marec-Bérard; Thierry Philip; Jean-Yves Blay
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):307-15.
2004: Jean-Yves Blay; ISABELLE RAY COQUARD; laurent alberti; Dominique Ranchère
Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.
Cancer treatment and research 2004;120():151-67.
2003: Perrine Marec-Berard; Jean Yves Blay; Matthias Schell; Murielle Buclon; Corrine Demaret; ISABELLE RAY COQUARD
Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4235-8.
2003: ISABELLE RAY COQUARD; Dominique Ranchère-Vince; Philippe Thiesse; Hervé Ghesquières; Pierre Biron; Marie-Pierre Sunyach; Michel Rivoire; L Lancry; Pierre Méeus; Catherine Sebban; Jean-Yves Blay
Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses.
European journal of cancer (Oxford, England : 1990) 2003;39(14):2021-5.
2003: Vincent Baty; Véronique Michalet; Philippe Tanière; Philippe Chalabreysse; Bernard Magnin; ISABELLE RAY COQUARD
[Peritoneal carcinomatosis and hepatic infiltration related to the dissemination of a micropapillary cell carcinoma of the bladder].
Gastroentérologie clinique et biologique 2003;27(8-9):828-32.
2003: Thomas Bachelot; ISABELLE RAY COQUARD; Christine Menetrier-Caux; M Rastkha; Adeline Duc; Jean-Yves Blay
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
British journal of cancer 2003;88(11):1721-6.
2003: ISABELLE RAY COQUARD; Thomas Bachelot; Catherine Sebban; Pierre Biron; Jean-Paul Guastalla; Jean-Yves Blay
[Anemia and chemotherapy].
Bulletin du cancer 2003;90 Spec No():S133-43.
2003: ISABELLE RAY COQUARD; Thomas Bachelot; Jean-Paul Guastalla; Eric Levy; Jean-Dominique Tigaud; Pascal Vincent; Dominique Dramais; David Assouline; Eric Pujade-Lauraine
Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimens.
Gynecologic oncology 2003;88(3):351-7.
2003: ISABELLE RAY COQUARD; Christophe Borg; Thomas Bachelot; Catherine Sebban; Irène Philip; Gilles Clapisson; Axel Le Cesne; Pierre Biron; Franck Chauvin; Jean-Yves Blay
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy.
British journal of cancer 2003;88(2):181-6.
2003: ISABELLE RAY COQUARD; Axel Le Cesne; Véronique Michallet; Ioannis Boukovinas; Dominique Ranchere; Philippe Thiesse; Vincent Baty; Jean-Yves Blay
[Gastro-intestinal stromal tumors: news and comments].
Bulletin du cancer 2003;90(1):69-76.
2002: Thomas Bachelot; Frédéric Gomez; Pierre Biron; ISABELLE RAY COQUARD; P Soler-Michel; Irène Philip; Jean-Paul Guastalla; Paul Rebattu; Arlette Dumortier; Jean Pierre Droz; Jean-Yves Blay
A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.
British journal of cancer 2002;87(10):1079-85.
2002: Thomas Bachelot; ISABELLE RAY COQUARD; David Coeffic; Hugues Barletta; Marie-Claude Gouttebel; Bernard Mayer; Thierry Muron; Guy De Laroche; Michel Vincent; Fadila Farsi; Thierry Philip
[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].
Bulletin du cancer 2002;89(10):897-903.
2002: ISABELLE RAY COQUARD; Jean-Yves Blay
[Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].
Bulletin du cancer 2002;89(6):567-9.
2002: ISABELLE RAY COQUARD; Thierry Philip; Guy De Laroche; X Froger; Jean-Philippe Suchaud; A Voloch; H Mathieu-Daudé; Béatrice Fervers; Fadila Farsi; G P Browman; Franck Chauvin
A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practice.
British journal of cancer 2002;86(3):313-21.
2001: ISABELLE RAY COQUARD; Hervé Ghesquière; Thomas Bachelot; Christophe Borg; Pierre Biron; Catherine Sebban; A LeCesne; Franck Chauvin; Jean-Yves Blay
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
British journal of cancer 2001;85(6):816-22.
2001: ISABELLE RAY COQUARD; Pierre Biron; Jean-Yves Blay
[High-dose chemotherapy in soft tissue sarcomas of adults].
Bulletin du cancer 2001;88(9):858-62.
2001: ISABELLE RAY COQUARD; A L Cesne; J Y Blay
[STI571 and gastro intestinal stromal tumors].
Bulletin du cancer 2001;88(7):661-2.
2001: Vincent Baty; ISABELLE RAY COQUARD; S Roman; Roger-Michel Bory
BCG therapy-related death and previous pelvic radiation.
The Annals of pharmacotherapy 2001;35(7-8):963-4.
2000: Jean-Yves Blay; D Bouhour; ISABELLE RAY COQUARD; Charles Dumontet; T Philip; P Biron
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21):3643-50.
2000: Gisèle Chvetzoff; ISABELLE RAY COQUARD; Arlette Dumortier; C Engel; M F Mevelec; J F Latour; Thierry Philip; Franck Chauvin
[Huriet law: application in a regional cancer centre (Centre Léon-Bérard, Lyon)].
Bulletin du cancer 2000;87(9):671-9.
2000: Dominique Mille; T Roy; Marie-Odile Carrère; ISABELLE RAY COQUARD; N Ferdjaoui; Hans-Martin Späth; Franck Chauvin; T Philip
Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1718-24.
2000: Thomas Bachelot; ISABELLE RAY COQUARD; Gilles Catimel; Claude Ardiet; Jean-Paul Guastalla; Arlette Dumortier; Franck Chauvin; Jean Pierre Droz; Thierry Philip; MD Clavel
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):151-6.
1999: ISABELLE RAY COQUARD; A Le Cesne; M T Rubio; J Mermet; C Maugard; Alain Ravaud; Christine Chevreau; Catherine Sebban; Thomas Bachelot; Pierre Biron; J Y Blay
Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2840-6.
1998: J Y Blay; A Le Cesne; C Mermet; C Maugard; Alain Ravaud; Christine Chevreau; Catherine Sebban; J Guastalla; Pierre Biron; ISABELLE RAY COQUARD
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy.
Blood 1998;92(2):405-10.
1998: ISABELLE RAY COQUARD; Pierre Biron; Thomas Bachelot; Jean-Paul Guastalla; Gilles Catimel; Yacine Merrouche; Jean Pierre Droz; Franck Chauvin; Jean-Yves Blay
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Cancer 1998;82(1):134-40.
1997: ISABELLE RAY COQUARD; Thierry Philip; M Lehmann; Béatrice Fervers; Fadila Farsi; Franck Chauvin
Impact of a clinical guidelines program for breast and colon cancer in a French cancer center.
JAMA : the journal of the American Medical Association 1997;278(19):1591-5.
1997: ISABELLE RAY COQUARD; Michel Bolla; Emile Reyt; D Brochon; Jacques Lebeau; M Colonna; H Kolodié; F Vincent; J Chinal-Provencal
[Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].
Bulletin du cancer 1997;84(9):863-8.